Gynecologic oncology care during the COVID-19 pandemic at three affiliated New York City hospitals.

CONCLUSIONS: More than one third of patients with gynecologic cancer at three affiliated New York City hospitals experienced a treatment delay, change or cancellation during the first two months of the COVID-19 pandemic. Among the three New York City boroughs represented in this study, likelihood of gynecologic oncology treatment modifications correlated with the case burden of COVID-19. PMID: 32981694 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32981694?dopt=Abstract

Source: Gynecologic Oncology - September 23, 2020 Category: Cancer & Oncology Authors: Frey MK, Fowlkes RK, Badiner NM, Fishman D, Kanis M, Thomas C, Christos PJ, Martin P, Gamble C, Balogun OD, Cardenes H, Gorelick C, Pua T, Nguyen L, Holcomb K, Chapman-Davis E Tags: Gynecol Oncol Source Type: research